Company Data

VYNE Therapeutics Inc.

Ticker
VYNE
Current Price
$1.43 -23.94%
Market Cap
$21.8M
Price Target
Refer to Report
Volume
1.7M
52wk Range
$1.44 - $4.3
Advanced Market Data

Overview

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy